{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:04:40Z","timestamp":1792011880503,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03736-y","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T06:18:29Z","timestamp":1755325109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating long-term outcomes after cytoreductive surgery for colorectal peritoneal metastasis: do long survivors really exist?"],"prefix":"10.1186","volume":"23","author":[{"given":"Giorgio","family":"D\u2019Annibale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Aulicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Abatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Barberis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lodoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Attalla El","family":"Halabieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ferracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alessandra","family":"Calegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Santullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"3736_CR1","unstructured":"Clinical presentation, diagnosis, and staging of colorectal cancer. Available from: https:\/\/medilib.ir\/uptodate\/show\/2496. Cited 2024 Sep 11."},{"key":"3736_CR2","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27743922\/. Cited 2024 Sep 11.","journal-title":"Lancet Oncol"},{"key":"3736_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22162570\/. Cited 2024 Sep 11.","journal-title":"J Clin Oncol"},{"key":"3736_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19103728\/. Cited 2024 Sep 11","journal-title":"J Clin Oncol"},{"key":"3736_CR5","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284\u201392. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15310771\/. Cited 2024 Sep 11.","journal-title":"J Clin Oncol"},{"key":"3736_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s13193-016-0499-z","volume":"7","author":"A Bhatt","year":"2016","unstructured":"Bhatt A, Go\u00e9r\u00e9 D. Cytoreductive surgery plus HIPEC for peritoneal metastases from colorectal cancer. Indian J Surg Oncol. 2016;7:177\u201387. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27065708\/. Cited 2024 Sep 11.","journal-title":"Indian J Surg Oncol"},{"key":"3736_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF00308632","volume":"19","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg. 1995;19:235\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/7754629\/. Cited 2024 Sep 11.","journal-title":"World J Surg"},{"key":"3736_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/CMAR.S119569","volume":"9","author":"GA Simkens","year":"2017","unstructured":"Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH. Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res. 2017;9:259. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5501638\/. Cited 2024 Dec 5.","journal-title":"Cancer Manag Res"},{"key":"3736_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138. Available from: https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2009.23.9285. Cited 2025 Feb 6.","journal-title":"J Clin Oncol"},{"key":"3736_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10434-004-1167-z","volume":"12","author":"VJ Verwaal","year":"2005","unstructured":"Verwaal VJ, Van Ruth S, Witkamp A, Boot H, Van Slooten G, Zoetmulder FAN. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2005;12:65\u201371. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15827780\/. Cited 2025 Feb 5.","journal-title":"Ann Surg Oncol"},{"key":"3736_CR11","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1245\/s10434-021-11045-3","volume":"29","author":"M Tonello","year":"2022","unstructured":"Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, et al. Microsatellite and RAS\/RAF mutational status as prognostic factors in colorectal peritoneal metastases treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2022;29:3405\u201317. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34783946\/ . Cited 2025 Feb 5.","journal-title":"Ann Surg Oncol"},{"key":"3736_CR12","doi-asserted-by":"crossref","unstructured":"Kamada Y, Hida K, Ishibashi H, Sako S, Mizumoto A, Ichinose M, et al. Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study. World J Surg Oncol. 2021;19. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33509224\/.","DOI":"10.1186\/s12957-021-02145-1"},{"key":"3736_CR13","doi-asserted-by":"crossref","unstructured":"Kamada Y, Hida K, Yonemura Y, Sugarbaker PH, Ghabra S, Ishihara S, et al. The characteristics of 206 long-term survivors with peritoneal metastases from colorectal cancer treated with curative intent surgery: a multi-center cohort from PSOGI. Cancers (Basel). 2021;13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34199234\/.","DOI":"10.3390\/cancers13122964"},{"key":"3736_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejca.2008.10.030","volume":"45","author":"DJ Sargent","year":"2009","unstructured":"Sargent DJ, Rubinstein L, Schwartz L, Dancey JE, Gatsonis C, Dodd LE, et al. Validation of novel imaging methodologies for use as cancer clinical trial end-points. Eur J Cancer. 2009;45:290\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19091547\/ . Cited 2025 Feb 5.","journal-title":"Eur J Cancer"},{"key":"3736_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, De Vries E, Ford R, Gwyther S, Mandrekar S, et al. RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer. 2016;62:132\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27189322\/ . Cited 2025 Feb 5.","journal-title":"Eur J Cancer"},{"key":"3736_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000513353","volume":"38","author":"NL De Boer","year":"2021","unstructured":"De Boer NL, Brandt-Kerkhof ARM, Madsen EVE, Doukas M, Verhoef C, Burger JWA. The accuracy of the surgical peritoneal cancer index in patients with peritoneal metastases of colorectal cancer. Dig Surg. 2021;38:205\u201311. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33657551\/ . Cited 2024 Sep 11.","journal-title":"Dig Surg"},{"key":"3736_CR17","doi-asserted-by":"crossref","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29. Available from: \/pmc\/articles\/PMC1234492\/?report=abstract. Cited 2024 Sep 11.","DOI":"10.1097\/00000658-199501000-00004"},{"key":"3736_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/ejso.2000.1038","volume":"27","author":"PH Sugarbaker","year":"2001","unstructured":"Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001;27:239\u201343. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11373099\/ . Cited 2024 Sep 11.","journal-title":"Eur J Surg Oncol"},{"key":"3736_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, De Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19638912\/. Cited 2024 Sep 11.","journal-title":"Ann Surg."},{"key":"3736_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","volume":"158","author":"A Arjona-S\u00e1nchez","year":"2023","unstructured":"Arjona-S\u00e1nchez A, Espinosa-Redondo E, Guti\u00e9rrez-Calvo A, Segura-Sampedro JJ, P\u00e9rez-Viejo E, Concepci\u00f3n-Mart\u00edn V, et al. Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial. JAMA Surg. 2023;158:683\u201391. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37099280\/ . Cited 2024 Sep 11.","journal-title":"JAMA Surg"},{"key":"3736_CR21","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s13304-021-01034-2","volume":"73","author":"S Rotolo","year":"2021","unstructured":"Rotolo S, Di Giorgio A, Santullo F, Attalla El Halabieh M, Lodoli C, Abatini C, et al. Cytoreductive surgery and mitomycin C hyperthermic intraperitoneal chemotherapy with CO2 recirculation (HIPEC-CO2) for colorectal cancer peritoneal metastases: analysis of short-term outcomes. Updates Surg. 2021;73:1443\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33782856\/ . Cited 2024 Sep 11.","journal-title":"Updates Surg"},{"key":"3736_CR22","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.ejso.2018.07.003","volume":"44","author":"M Bushati","year":"2018","unstructured":"Bushati M, Rovers KP, Sommariva A, Sugarbaker PH, Morris DL, Yonemura Y, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2018;44:1942\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30075978\/ . Cited 2024 Sep 11.","journal-title":"Eur J Surg Oncol"},{"key":"3736_CR23","doi-asserted-by":"crossref","unstructured":"Di Giorgio A, Santullo F, Attalla El Halabieh M, Lodoli C, Abatini C, Calegari MA, et al. Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer. J Gastrointest Surg. 2021;25:2649\u201359. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34244953\/. Cited 2024 Sep 11.","DOI":"10.1007\/s11605-021-05073-3"},{"key":"3736_CR24","doi-asserted-by":"crossref","unstructured":"Sarofim M, Wijayawardana R, Ahmadi N, Morris DL. Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review. World J Surg Oncol. 2024;22. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38627808\/. Cited 2024 Sep 28.","DOI":"10.1186\/s12957-024-03386-6"},{"key":"3736_CR25","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284\u201392. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15310771\/. Cited 2024 Sep 28.","journal-title":"J Clin Oncol."},{"key":"3736_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.04.023","volume":"215","author":"KI Votanopoulos","year":"2012","unstructured":"Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215:412\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22634117\/ . Cited 2024 Sep 28.","journal-title":"J Am Coll Surg"},{"key":"3736_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ags3.12515","volume":"6","author":"K Yoshida","year":"2021","unstructured":"Yoshida K, Yasufuku I, Terashima M, Young Rha S, Moon Bae J, Li G, et al. International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1). Ann Gastroenterol Surg. 2021;6:227\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35261948\/. Cited 2024 Sep 11.","journal-title":"Ann Gastroenterol Surg"},{"key":"3736_CR28","doi-asserted-by":"crossref","unstructured":"Santullo F, Ferracci F, Abatini C, Halabieh MA El, Lodoli C, D\u2019Annibale G, et al. Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments. Langenbecks Arch Surg. 2023;408. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37973620\/. Cited 2024 Sep 11.","DOI":"10.1007\/s00423-023-03163-1"},{"key":"3736_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8\u201310. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/7799047\/ . Cited 2024 Sep 11.","journal-title":"J Clin Oncol"},{"key":"3736_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","volume":"133","author":"S Paget","year":"1889","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. The Lancet. 1889;133:571\u20133.","journal-title":"The Lancet"},{"key":"3736_CR31","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s11605-019-04441-4","volume":"24","author":"L Xue","year":"2020","unstructured":"Xue L, Hyman NH, Turaga KK, Eng OS. Peritoneal metastases in colorectal cancer: biology and barriers. J Gastrointest Surg. 2020;24:720\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31745890\/ . Cited 2024 Sep 28.","journal-title":"J Gastrointest Surg"},{"key":"3736_CR32","doi-asserted-by":"crossref","unstructured":"Burnett A, Lecompte MEA, Trabulsi N, Dub\u00e9 P, Gervais MK, Trilling B, et al. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study. World J Surg Oncol. 2019;17. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31092250\/. Cited 2024 Sep 11.","DOI":"10.1186\/s12957-019-1618-4"},{"key":"3736_CR33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1080\/02656736.2017.1351627","volume":"34","author":"A Brandl","year":"2018","unstructured":"Brandl A, Weiss S, von Winterfeld M, Krannich A, Feist M, Pratschke J, et al. Predictive value of peritoneal cancer index for survival in patients with mucinous peritoneal malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience. Int J Hyperthermia. 2018;34:512\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28679331\/ . Cited 2024 Sep 11.","journal-title":"Int J Hyperthermia"},{"key":"3736_CR34","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/annonc\/mdx401","volume":"28","author":"E Sanz-Garcia","year":"2017","unstructured":"Sanz-Garcia E, Argiles G, Elez E, Tabernero J. BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives. Ann Oncol. 2017;28:2648\u201357. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29045527\/ . Cited 2024 Sep 11.","journal-title":"Ann Oncol"},{"key":"3736_CR35","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","volume":"268","author":"MA Schneider","year":"2018","unstructured":"Schneider MA, Eden J, Pache B, Laminger F, Lopez-Lopez V, Steffen T, et al. Mutations of RAS\/RAF proto-oncogenes impair survival after cytoreductive surgery and HIPEC for peritoneal metastasis of colorectal origin. Ann Surg. 2018;268:845\u201353. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30303876\/. Cited 2024 Sep 11.","journal-title":"Ann Surg"},{"key":"3736_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1245\/s10434-019-07452-2","volume":"27","author":"W Graf","year":"2020","unstructured":"Graf W, Cashin PH, Ghanipour L, Enblad M, Botling J, Terman A, et al. Prognostic impact of BRAF and KRAS mutation in patients with colorectal and appendiceal peritoneal metastases scheduled for CRS and HIPEC. Ann Surg Oncol. 2020;27:293\u2013300. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31571052\/ . Cited 2024 Sep 11.","journal-title":"Ann Surg Oncol"},{"key":"3736_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41416-021-01620-6","volume":"126","author":"SG Larsen","year":"2022","unstructured":"Larsen SG, Goscinski MA, Dueland S, Steigen SE, Hofsli E, Torgunrud A, et al. Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients. Br J Cancer. 2022;126:726\u201335. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34887523\/ . Cited 2024 Sep 11.","journal-title":"Br J Cancer"},{"key":"3736_CR38","doi-asserted-by":"crossref","unstructured":"Wu Z, Qin X, Zhang Y, Luo J, Luo R, Cai Z, et al. Effect of BRAF mutation on the prognosis for patients with colorectal cancer undergoing cytoreductive surgery for synchronous peritoneal metastasis. Gastroenterol Rep (Oxf). 2023;11. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37886242\/. Cited 2024 Sep 11.","DOI":"10.1093\/gastro\/goad061"},{"key":"3736_CR39","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/ng1834","volume":"38","author":"DJ Weisenberger","year":"2006","unstructured":"Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38:787\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16804544\/ . Cited 2024 Sep 11.","journal-title":"Nat Genet"},{"key":"3736_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/jclinpath-2011-200340","volume":"65","author":"J Verhulst","year":"2012","unstructured":"Verhulst J, Ferdinande L, Demetter P, Ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol. 2012;65:381\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22259177\/ . Cited 2024 Sep 11.","journal-title":"J Clin Pathol"},{"key":"3736_CR41","doi-asserted-by":"crossref","unstructured":"Herold Z, Acs M, Szasz AM, Olasz K, Hussong J, Mayr M, et al. Patients with metachronous peritoneal metastatic mucinous colorectal adenocarcinoma benefit more from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than their synchronous counterparts. Cancers (Basel). 2022;14. Available from:  https:\/\/pubmed.ncbi.nlm.nih.gov\/36010972\/. Cited 2024 Sep 11.","DOI":"10.3390\/cancers14163978"},{"key":"3736_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/jso.1111","volume":"77","author":"PH Sugarbaker","year":"2001","unstructured":"Sugarbaker PH. Mucinous colorectal carcinoma. J Surg Oncol. 2001;77:282\u20133. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11473380\/ . Cited 2024 Sep 11.","journal-title":"J Surg Oncol"},{"key":"3736_CR43","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/ijc.25596","volume":"128","author":"VE Lemmens","year":"2011","unstructured":"Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JWW, De Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128:2717\u201325. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20715167\/ . Cited 2024 Sep 11.","journal-title":"Int J Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03736-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03736-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:51:04Z","timestamp":1757429464000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03736-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3736"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03736-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the ethical guidelines of the Declaration of Helsinki, and all clinical information was anonymized and deidentified prior to analysis.Informed consent was obtained from all subjects involved in the study at the moment of hospital admission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained with informed consent at the moment of hospital admission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"313"}}